Defeat IC

It is estimated that as many as 10 million men and women in the US alone suffer from interstitial cystitis (IC).

Defeat IC

Doctor Explaining Report To Patient In Hospital

IC is characterized by bladder pressure, bladder pain, urinary urgency, and urinary frequency. In severe cases, patients may need to urinate up to 60 times per day.1 Most IC patients experience flares, times during which symptoms can worsen dramatically.

Achieving a timely diagnosis

Too often, clinicians arrive at a diagnosis of IC only by ruling out many other diseases and complications, including urinary tract infections, bladder infections, bladder stones, STDs, and other conditions that may cause similar symptoms.

Patients can also be given a self-reported Pelvic Pain and Urgency/Frequency (PUF) Questionnaire. The PUF Questionnaire can be considered a key tool in the diagnosis of IC by accurately and efficiently understanding the severity of the symptoms associated with IC ultimately to help get your patients on the road to immediate treatment.

Treatment options for IC

To date, treatment options for IC symptoms have relied heavily on behavioral changes (eg, diet modifications and self-management) and oral medications (eg, Elmiron and antidepressants) that may take months to be effective.

Bladder instillations, included in the American Urological Association (AUA) treatment guidelines for IC, provide immediate treatment because medication is delivered directly to the bladder.

PPS-DR compounded formulations

Pentosan Polysulfate SodiumPPS-DR* is a compounded formulation that has been prescribed as a low cost alternative for the treatment of interstitial cystitis. The compounded formulation is carefully prepared for individually identified patients in delayed release capsules in amounts that may meet your patients’ specific needs and allows for dosing as little as twice daily for your patients. Click here for more details on PPS-DR.

Our compounded formulation provides:

  • Improved patient experience
  • Affordability for your patients
  • Increased convenience with as little as twice daily dosing
formualtion search


Search our compounded formulations

*For professional use only. Imprimis Pharmaceuticals specializes in customizing medications to meet unique patient and practitioner needs. Imprimis Pharmaceuticals dispenses only to individually identified patients with valid prescriptions. No compounded medication is reviewed by the FDA for safety or efficacy. Imprimis Pharmaceuticals does not compound copies of commercially available products. References available upon request. There is not a specific HCPCS billing code that describes our compounded formulations. For any questions regarding coding or billing, please contact the payor directly.

References: 1.Interstitial Cystitis Association. Available at: Accessed February 6, 2015.